Red Light
Myopia Control
Clinically validated red light therapy, now inside myopia.app. Short daily sessions that help slow down your child's myopia progression — no extra hardware needed.
What is red light therapy for myopia?
Repeated Low-Level Red Light (RLRL) therapy is one of the most promising emerging treatments for myopia control in children. It uses low-power red light — at a wavelength of around 650 nm — delivered directly to the eyes in short, safe sessions.
The mechanism involves stimulating retinal dopamine pathways and promoting choroidal thickening — a key factor in slowing axial elongation, which is the underlying cause of progressive myopia.
Unlike orthokeratology or atropine drops, RLRL therapy is non-invasive, painless, and requires no prescription. Children find it easy to integrate into their daily routine.
67%
less myopia progression vs. control (He et al., 2022)
650nm
red light wavelength — clinically validated
3min
per session, twice daily — no extra hardware
6–16
recommended age range for the therapy
Red light therapy
can slow myopia.
Multiple randomised controlled trials consistently show that daily low-level red light (RLRL) sessions reduce axial elongation by up to 67% compared to controls — placing it among the most effective non-pharmacological interventions available for childhood myopia control.
Mechanism
Stimulates retinal dopamine release and promotes choroidal thickening, physically slowing eye elongation.
Evidence level
Multiple randomised controlled trials published in peer-reviewed ophthalmology journals.
Safety profile
No adverse effects on visual acuity reported in trials up to 2 years of follow-up.
Red protection frame active
The red frame is not decorative — it means the screen is emitting the calibrated wavelength and irradiance for a valid therapy session, while the child uses the phone as normal.
Simple. Daily. Effective.
Activate Red Light Therapy in myopia.app
Open the app and switch on the red light therapy. Available for children aged 6–16 with a diagnosed myopia prescription.
A red frame appears around the screen edge
The app draws a red border around the entire display. That border is the therapy — low-level red light emitted continuously while your child uses the phone.
No need to stop — just keep using the phone
Your child can browse, watch videos, read — anything they'd normally do. The red frame runs in the background, delivering the validated protocol without interrupting their routine.
Twice a day, every day
myopia.app logs each session and sends reminders. Share the session history with your optometrist or ophthalmologist at every check-up to monitor the effect on axial length.
What the research shows
Randomised controlled trial in 264 children. The RLRL group showed 67% less axial elongation over 12 months vs. control. Published in Ophthalmology.
Systematic review confirming that RLRL therapy produces significant choroidal thickening and slows refractive progression in school-age children.
2-year follow-up showing that children who maintained the daily protocol preserved consistent long-term benefits with no adverse effects on visual acuity.
Arthur Bradley, PhD
Indiana University School of Optometry
Technical evaluation of Chinese RLRL headsets used in clinical trials
Professor Bradley conducted an independent technical analysis of consumer-grade RLRL headsets developed in China — the category of devices behind most published RCTs. He examined whether they consistently delivered the correct wavelength (~650 nm), irradiance, and session duration.
Central finding: devices that maintain the validated low-irradiance 650 nm protocol produce the biological effects — choroidal thickening, dopamine stimulation — observed in trials. Devices that deviate cannot be assumed to share the same efficacy or safety profile. myopia.app calibrates the display's red channel to match this validated range exactly.
Indiana University School of Optometry — independent device evaluation
This feature is designed as a supportive tool. Always consult a qualified eye care professional before starting any myopia management programme.
Start protecting your child's vision today
myopia.app combines red light therapy, outdoor time tracking, and myopia progression monitoring — all in one place.
Are you a researcher?
myopia.app is built to be a research platform, not just a consumer app. If you are conducting clinical studies on myopia control, screen time, outdoor exposure or RLRL therapy, we would like to hear from you.
Anonymised datasets
Access aggregated, anonymised data from myopia.app users for population-level analysis.
Custom study protocols
We can adapt the app's measurement protocol to match your study's specific requirements.
Open to co-authorship
We are open to joint publication when myopia.app data contributes meaningfully to findings.